Offer - Urjas Oil for just ₹ 1 X
Caviter Rhe is a prescription medicine that is available as a Tablet. Tuberculosis are some of its major therapeutic uses.
The optimal dosage of Caviter Rhe is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
The side effects typically associated with Caviter Rhe include Hallucinations, Disorientation, Confusion. Some other side effects of Caviter Rhe have been listed ahead. These side effects of Caviter Rhe are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Caviter Rhe has a Moderate effect for pregnant women and Unknown effect on lactating mothers. In addition, Caviter Rhe's effects on the liver, heart and kidney are discussed below in the Caviter Rhe related warnings section.
Other conditions have been mentioned below in the Caviter Rhe contraindications section.
Additionally, Caviter Rhe may also adversely react with other medicines. A complete list of these interactions is given below.
In addition to the above precautions for Caviter Rhe, it is important to know that it is not safe while driving, and is not habit-forming.
Caviter Rhe is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Caviter Rhe safe for pregnant women?
Caviter Rhe may have some side effects during pregnancy. Pregnant women should discontinue the use of Caviter Rhe, and talk to their doctor, if they notice any discomfort.
Is the use of Caviter Rhe safe during breastfeeding?
There is no research available on the side effects of Caviter Rhe in breastfeeding women. Therefore, its impact is unknown.
What is the effect of Caviter Rhe on the Kidneys?
There can be some harmful effects on your kidneys after taking Caviter Rhe. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Caviter Rhe on the Liver?
The liver can be affected by Caviter Rhe. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Caviter Rhe only after medical advice.
What is the effect of Caviter Rhe on the Heart?
Information about safety of Caviter Rhe for heart is not available since scientific research on this is yet to be done.
Caviter Rhe should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Caviter Rhe unless your doctor advises you to do so -
Is this Caviter Rhe habit forming or addictive?
No, there is no any evidence that Caviter Rhe is addictive.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Caviter Rhe. So it is best to avoid driving.
Is it safe?
Caviter Rhe is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, the use of Caviter Rhe in mental disorders is not effective.
Interaction between Food and Caviter Rhe
Due to the absence of research, it is difficult to say how Caviter Rhe and food will interact.
Interaction between Alcohol and Caviter Rhe
Consuming Caviter Rhe with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rifadin (rifampin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 767-768
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Isoniazid
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 765-767
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 715-716
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Myambutol (ethambutol hcl)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 769
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 535-536
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 768-769
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1066-1067